(Q46158806)

20 December 2017

title

DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer (English)

1 reference

20 December 2017

1 reference

1 reference

7

1 reference

20 December 2017

author name string

C Postma

1

1 reference

20 December 2017

M Koopman

2

1 reference

20 December 2017

T E Buffart

3

1 reference

20 December 2017

P P Eijk

4

1 reference

20 December 2017

B Carvalho

5

1 reference

20 December 2017

G J Peters

6

1 reference

20 December 2017

J H van Krieken

8

1 reference

20 December 2017

C J A Punt

9

1 reference

20 December 2017

G A Meijer

10

1 reference

20 December 2017

publication date

15 January 2009

1 reference

20 December 2017

published in

Annals of Oncology

1 reference

20 December 2017

volume

20

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

1048-1056

1 reference

20 December 2017

New options and old dilemmas in the treatment of patients with advanced colorectal cancer

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Human and mouse oligonucleotide-based array CGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Global variation in copy number in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

CGHcall: calling aberrations for array CGH tumor profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Weighted clustering of called array CGH data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

A comparison study: applying segmentation to array CGH data for downstream analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

Cancer incidence and mortality in Europe, 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN738

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDN738

1 reference

20 December 2017

release_ls64ev75srazlj3yiht7nl5txy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ls64ev75srazlj3yiht7nl5txy

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

19150955

1 reference

20 December 2017